ATX-IN-2

CAT: 0804-HY-174267SSize: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-174267SSize:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
ATX-IN-2 (Compound 25) is an orally active and potent ATX inhibitor with an IC50 value of 3.27 nM. ATX-IN-2 reduces lysophosphatidic acid (LPA) secretion. ATX-IN-2 is promising for research of ATX-mediated diseases, such as inflammation, pulmonary fibrosis[1].
CAS Number
[3076224-81-9]
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
O=C(N1CC2(COC2)C1)C3(CC3)N4CCN(C(S5)=NN6C5=NC(CC)=C6N(C([2H])([2H])[2H])C7=NC(C8=CC=C(F)C=C8)=C(C#N)S7)CC4
Molecular Formula
C30H29D3FN9O2S2
Molecular Weight
636.78
References & Citations
[1]Wang H, et al. Successive structural optimization of Ziritaxestat culminates in the discovery of orally bioavailable and in vivo potent imidazothiadiazole derivative for treating ATX-driven diseases. Eur J Med Chem. 2025 May 21;295:117769.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-149167-01ATX-0126
HY-145739-01ATX-0114
HY-P1604-01ATX-II
HY-W590548ATX-001
HY-169071SATX-1905
HY-175537ATX-IN-3
HY-142654-01ATX-002
HY-N16293ATX-95
HY-170765ATX-IN-1
HY-143583ATX inhibitor 10

Alternative Products

CatalogName
MBS5821698ATX-II
465714ATX-002
OR1005041-01ATX-0126
MF-0063723-01ATX-IN-3
MF-0063722-01ATX-IN-1
MF-0063716-01ATX-001
JH919918ATX-100
BA7914-10ATX-0114
MF-0063719-01ATX-95

Popular Products